谈判成功!百万1针的CAR-T疗法有望纳入创新药目录

制药网
Nov 03

今年,国家医保局迎来成立后的第八次医保目录调整,其中头次在基本医保目录之外增设商保创新药目录的举措。这一突破性变革,不仅打破了过往支付端的单一格局,更以 “基本医保保基本、商业健康险保创新” 的协同模式,为创新药临床应用打通了关键堵点,尤其让曾因 “天价” 屡屡无缘医保的 CAR-T疗法,迎来了落地患者身边的新曙光。​据悉,11月2日,2025国家医保谈判进行的第四天。合源生物谈判代表结束价格协商...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10